These 3’ EPCAM deletions and associated MSH2 epimutations account for 1%–3% of the molecular defects identified in LS patients and are conveniently detectable by MLPA in epithelial tissues [132,133]. The gene discussed is MSH2; the disease is Leigh syndrome.